Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2019
Table of Contents
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2018
1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview
- 1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
- 1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type (Product Category)
- 1.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
- 1.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Market Share by Type (Product Category) in 2017
- 1.2.3 Afatinib Dimaleate
- 1.2.3 Dacomitinib
- 1.2.5 Neratinib
- 1.2.6 Neucardin
Others
- 1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Application
- 1.3.1 Receptor Tyrosine Protein Kinase Targeted Drugs Consumption (Sales) Comparison by Application (2013-2025)
- 1.3.2 Oncology
- 1.3.3 Cardiovascular
- 1.3.4 Central Nervous System
- 1.3.5 Others
- 1.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region (2013-2025)
- 1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
- 1.4.2 North America Status and Prospect (2013-2025)
- 1.4.3 Europe Status and Prospect (2013-2025)
- 1.4.4 China Status and Prospect (2013-2025)
- 1.4.5 Japan Status and Prospect (2013-2025)
- 1.4.6 Southeast Asia Status and Prospect (2013-2025)
- 1.4.7 India Status and Prospect (2013-2025)
- 1.5 Global Market Size (Value) of Receptor Tyrosine Protein Kinase Targeted Drugs (2013-2025)
- 1.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Status and Outlook (2013-2025)
- 1.5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Manufacturers
- 2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production and Share by Manufacturers (2013-2018)
- 2.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity and Share by Manufacturers (2013-2018)
- 2.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production and Share by Manufacturers (2013-2018)
- 2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Manufacturers (2013-2018)
- 2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Price by Manufacturers (2013-2018)
- 2.4 Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area and Product Type
- 2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
- 2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate
- 2.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
- 3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity and Market Share by Region (2013-2018)
- 3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production and Market Share by Region (2013-2018)
- 3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) and Market Share by Region (2013-2018)
- 3.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.5 North America Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.6 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.7 China Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.8 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.9 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.10 India Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
- 4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Region (2013-2018)
- 4.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
- 4.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
- 4.4 China Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
- 4.5 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
- 4.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
- 4.7 India Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (Value), Price Trend by Type
- 5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production and Market Share by Type (2013-2018)
- 5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2013-2018)
- 5.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2013-2018)
- 5.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Growth by Type (2013-2018)
6 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis by Application
- 6.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption and Market Share by Application (2013-2018)
- 6.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Growth Rate by Application (2013-2018)
- 6.3 Market Drivers and Opportunities
- 6.3.1 Potential Applications
- 6.3.2 Emerging Markets/Countries
7 Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Profiles/Analysis
- 7.1 Aslan Pharmaceuticals Pte Ltd
- 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.1.2.1 Product A
- 7.1.2.2 Product B
- 7.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.1.4 Main Business/Business Overview
- 7.2 Boehringer Ingelheim GmbH
- 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.2.2.1 Product A
- 7.2.2.2 Product B
- 7.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.2.4 Main Business/Business Overview
- 7.3 GamaMabs Pharma SA
- 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.3.2.1 Product A
- 7.3.2.2 Product B
- 7.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.3.4 Main Business/Business Overview
- 7.4 Hanmi Pharmaceuticals Co Ltd
- 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.4.2.1 Product A
- 7.4.2.2 Product B
- 7.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.4.4 Main Business/Business Overview
- 7.5 Jiangsu Kanion Pharmaceutical Co Ltd
- 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.5.2.1 Product A
- 7.5.2.2 Product B
- 7.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
- 7.5.4 Main Business/Business Overview
- 7.6 Minerva Neurosciences Inc
- 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.6.2.1 Product A
- 7.6.2.2 Product B
- 7.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.6.4 Main Business/Business Overview
- 7.7 Pfizer Inc
- 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.7.2.1 Product A
- 7.7.2.2 Product B
- 7.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.7.4 Main Business/Business Overview
- 7.8 Puma Biotechnology Inc
- 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.8.2.1 Product A
- 7.8.2.2 Product B
- 7.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.8.4 Main Business/Business Overview
- 7.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
- 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.9.2.1 Product A
- 7.9.2.2 Product B
- 7.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.9.4 Main Business/Business Overview
- 7.8 XuanZhu Pharma Co Ltd
- 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
- 7.10.2.1 Product A
- 7.10.2.2 Product B
- 7.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.10.4 Main Business/Business Overview
- 7.11 Zensun (Shanghai) Sci & Tech Co Ltd
8 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
- 8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.1.4 Market Concentration Rate of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.2.1 Raw Materials
- 8.2.2 Labor Cost
- 8.2.3 Manufacturing Expenses
- 8.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
- 9.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
- 9.2 Upstream Raw Materials Sourcing
- 9.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2017
- 9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
11 Market Effect Factors Analysis
- 11.1 Technology Progress/Risk
- 11.1.1 Substitutes Threat
- 11.1.2 Technology Progress in Related Industry
- 11.2 Consumer Needs/Customer Preference Change
- 11.3 Economic/Political Environmental Change
12 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2018-2025)
- 12.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production, Revenue Forecast (2018-2025)
- 12.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
- 12.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate Forecast (2018-2025)
- 12.1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price and Trend Forecast (2018-2025)
- 12.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
- 12.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.5 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.6 India Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue and Price Forecast by Type (2018-2025)
- 12.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown and Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
This report studies the global Receptor Tyrosine Protein Kinase Targeted Drugs market status and forecast, categorizes the global Receptor Tyrosine Protein Kinase Targeted Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Afatinib Dimaleate
Dacomitinib
Neratinib
Neucardin
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Oncology
Cardiovascular
Central Nervous System
Others
The study objectives of this report are:
To analyze and study the global Receptor Tyrosine Protein Kinase Targeted Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Receptor Tyrosine Protein Kinase Targeted Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Receptor Tyrosine Protein Kinase Targeted Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers
Receptor Tyrosine Protein Kinase Targeted Drugs Distributors/Traders/Wholesalers
Receptor Tyrosine Protein Kinase Targeted Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Receptor Tyrosine Protein Kinase Targeted Drugs market, by end-use.
Detailed analysis and profiles of additional market players.